![](/img/cover-not-exists.png)
Case Series of Western Sydney's Experience with the Use of Mexiletine 150 mg Twice Daily as an Antiarrhythmic Drug in Ischaemic Cardiomyopathy Patients with Automated Implantable Cardioverter Defibrillators In-situ that Have Recurrent Ventricular Arrhythmias Refractory to Standard Treatment
Chong, J., Thomas, S., Chandrala, P., Lee, C.Volume:
26
Year:
2017
Language:
english
Journal:
Heart, Lung and Circulation
DOI:
10.1016/j.hlc.2017.06.266
File:
PDF, 64 KB
english, 2017